Japan· JP-4291400A1033
Ｌ－アスパラギナーゼ
A medicinal product containing ｌ－アスパラギナーゼ, registered in Japan by 協和キリン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- Ｌ－アスパラギナーゼ
- Manufacturer
- 協和キリン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ｌ－アスパラギナーゼ in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsparaginase 10,000unit powder for solution for injection vialsImported (Germany)
- BelgiumParonal 10000 IUTakeda Belgium
- CzechiaSPECTRILAMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- SwedenEnrylaze 10 mg/0,5 ml Injektions-/infusionsvätska, lösningJazz Pharmaceuticals Ireland Limited
- IcelandSpectrilamedac Gesellschaft für klinische Spezialpräparate GmbH
- NorwayEnrylazeJazz Pharmaceuticals Ireland Limited
- PolandSpectrilamedac Gesellschaft fuer klinische Spezialpraeparate mbH
- United StatesRylazeJazz Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enrylaze, Spectrila
- Liechtenstein · Enrylaze, Spectrila
- Norway · Enrylaze, Spectrila
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb245569-054f-4d79-b55f-32c212c7bfc3 GET /v1/drugs/fb245569-054f-4d79-b55f-32c212c7bfc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５，０００Ｋ単位１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291400A1033",
"category": "注射薬",
"price_yen": 4850,
"generic_name": "Ｌ－アスパラギナーゼ",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about ｌ－アスパラギナーゼ.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.